Related Experiment Videos
Intelligence and professional career in young adults treated early for phenylketonuria
Insights
Early treatment for phenylketonuria (PKU) in young adults leads to good intellectual and career outcomes. Effective phenylalanine control, especially in childhood, is crucial for maintaining cognitive function and professional success.
Area of Science:
- Metabolic disorders
- Neuroscience
- Genetics
Background:
- Phenylketonuria (PKU) is a genetic disorder requiring early intervention.
- Long-term intellectual and professional outcomes for PKU patients treated early are not fully understood.
Purpose of the Study:
- To describe the intellectual status and professional careers of young adults with PKU treated before 3 months of age.
- To investigate the correlation between phenylalanine (Phe) control and long-term outcomes.
Main Methods:
- Retrospective study of 51 young adults with PKU.
- Assessment of intellectual status (IQ) and professional careers.
- Analysis of phenylalanine control and its correlation with outcomes, considering social background.
Main Results:
- Mean IQ was 97 (SD=16), with 4% below -2 SD from the norm.
- Schooling and career paths were comparable to the general population.
- Phenylalanine control significantly correlated with better outcomes, particularly when managed early in life.
Conclusions:
- Early treatment and consistent phenylalanine control are vital for positive intellectual and professional development in PKU patients.
- The critical period for phenylalanine's impact on intelligence appears to be the first decade of life.
Abstract:
The intellectual status and professional careers of 51 young adults with phenylketonuria whose treatment started before 3 months of age are described. Their mean IQ was 97 (SD = 16). Of the IQs, 4% were more than 2 SD below the norm. The distribution of types of schooling of the patients was comparable to that in the German population. The professional careers of nearly all the patients were according to their educational level. Within the sample the outcome was significantly correlated with phenylalanine (Phe) control, even when the patients' social background was statistically taken into account. The main influence of Phe on intelligence seems to occur during the first decade of life since IQ data remain stable even after Phe levels increased during adolescence.